Cambridge Investment Research Advisors’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Cambridge Investment Research Advisors’s Portfolio RSPH Stock Details RSPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27M	Buy	38,201 +1,030	+3%	+$32K	﹤0.01%	2081
2026 Q1	$1.12M	Sell	37,171 -3,161	-8%	-$101K	﹤0.01%	2067
2025 Q4	$1.28M	Buy	40,332 +680	+2%	+$21.1K	﹤0.01%	1908
2025 Q3	$1.17M	Sell	39,652 -5,167	-12%	-$150K	﹤0.01%	1932
2025 Q2	$1.31M	Sell	44,819 -2,686	-6%	-$76.5K	﹤0.01%	1743
2025 Q1	$1.41M	Sell	47,505 -3,466	-7%	-$105K	﹤0.01%	1592
2024 Q4	$1.49M	Sell	50,971 -24,217	-32%	-$744K	0.01%	1570
2024 Q3	$2.42M	Sell	75,188 -86,166	-53%	-$2.7M	0.01%	1206
2024 Q2	$4.84M	Buy	161,354 +7,254	+5%	+$220K	0.02%	771
2024 Q1	$4.9M	Buy	154,100 +4,915	+3%	+$151K	0.02%	758
2023 Q4	$4.44M	Buy	149,185 +11,455	+8%	+$314K	0.02%	761
2023 Q3	$3.77M	Buy	137,730 +92,590	+205%	+$2.69M	0.02%	798
2023 Q2	$1.34M	Buy	45,140 +6,350	+16%	+$186K	0.01%	1416
2023 Q1	$1.13M	Buy	38,790 +3,150	+9%	+$91.6K	0.01%	1496
2022 Q4	$1.03M	Sell	35,640 -260	-0.7%	-$7.24K	0.01%	1497
2022 Q3	$902K	Sell	35,900 -62,010	-63%	-$1.7M	0.01%	1549
2022 Q2	$2.62M	Buy	97,910 +67,320	+220%	+$1.91M	0.01%	911
2022 Q1	$937K	Sell	30,590 -560	-2%	-$16.8K	﹤0.01%	1619
2021 Q4	$998K	Sell	31,150 -940	-3%	-$28.6K	﹤0.01%	1584
2021 Q3	$957K	Sell	32,090 -450	-1%	-$13.9K	﹤0.01%	1563
2021 Q2	$953K	Sell	32,540 -1,510	-4%	-$42.7K	﹤0.01%	1562
2021 Q1	$913K	Sell	34,050 -7,940	-19%	-$211K	0.01%	1490
2020 Q4	$1.1M	Sell	41,990 -22,420	-35%	-$558K	0.01%	1241
2020 Q3	$1.52M	Sell	64,410 -16,960	-21%	-$399K	0.01%	954
2020 Q2	$1.81M	Sell	81,370 -9,940	-11%	-$213K	0.01%	820
2020 Q1	$1.73M	Sell	91,310 -8,810	-9%	-$187K	0.02%	731
2019 Q4	$2.22M	Sell	100,120 -12,740	-11%	-$266K	0.02%	745
2019 Q3	$2.21M	Sell	112,860 -43,560	-28%	-$867K	0.02%	710
2019 Q2	$3.17M	Buy	156,420 +24,850	+19%	+$483K	0.03%	556
2019 Q1	$2.6M	Sell	131,570 -4,510	-3%	-$87K	0.02%	610
2018 Q4	$2.42M	Sell	136,080 -2,550	-2%	-$48.5K	0.03%	568
2018 Q3	$2.86M	Buy	138,630 +1,390	+1%	+$27.2K	0.03%	560
2018 Q2	$2.51M	Buy	137,240 +87,540	+176%	+$1.59M	0.03%	568
2018 Q1	$893K	Buy	49,700 +18,760	+61%	+$349K	0.01%	996
2017 Q4	$556K	Sell	30,940 -6,510	-17%	-$115K	0.01%	1262
2017 Q3	$656K	Sell	37,450 -9,620	-20%	-$167K	0.01%	1072
2017 Q2	$819K	Buy	47,070 +17,260	+58%	+$286K	0.01%	907
2017 Q1	$477K	Sell	29,810 -3,140	-10%	-$48.9K	0.01%	1106
2016 Q4	$481K	Buy	32,950 +4,410	+15%	+$65.2K	0.01%	1032
2016 Q3	$444K	Buy	28,540 +880	+3%	+$13.8K	0.01%	1103
2016 Q2	$417K	Buy	27,660 +2,690	+11%	+$40.1K	0.01%	1022
2016 Q1	$360K	Sell	24,970 -1,680	-6%	-$23.8K	0.01%	1076
2015 Q4	$409K	Buy	26,650 +6,550	+33%	+$97.8K	0.01%	953
2015 Q3	$282K	Sell	20,100 -44,700	-69%	-$699K	0.01%	1052
2015 Q2	$1.03M	Buy	64,800 +10,490	+19%	+$166K	0.03%	498
2015 Q1	$843K	Buy	54,310 +35,260	+185%	+$527K	0.02%	564
2014 Q4	$272K	Sell	19,050 -16,760	-47%	-$230K	0.01%	1058
2014 Q3	$462K	Buy	35,810 +4,300	+14%	+$54.6K	0.01%	871
2014 Q2	$389K	Buy	+31,510	New	+$373K	0.01%	874

Other funds holding RSPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

STA

Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WLPWM

Walled Lake Planning & Wealth Management Winnetka, Illinois $396M AUM 17.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Cambridge Investment Research Advisors's RSPH Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Invesco S&P 500 Equal Weight Health Care ETF (RSPH) stake by 2.8% in Q2 2026, buying an estimated $32K and bringing the position to 38,201 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Cambridge Investment Research Advisors first reported a position in RSPH in Q2 2014 and has held it in 49 quarters since. The position peaked at $4.9M in Q1 2024. 187 funds tracked by Wall St. Rank hold RSPH as of Q2 2026.

Cambridge Investment Research Advisors held 38,201 shares of Invesco S&P 500 Equal Weight Health Care ETF worth $1.27M as of Q2 2026.
Cambridge Investment Research Advisors bought 1,030 Invesco S&P 500 Equal Weight Health Care ETF shares in Q2 2026, an estimated $32K.
Invesco S&P 500 Equal Weight Health Care ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2081 holding.
Cambridge Investment Research Advisors first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q2 2014 and has held it in 49 quarters since.
Cambridge Investment Research Advisors's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $4.9M in Q1 2024.
187 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.